SEC Comment Letter for CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — Oct 11, 2018

CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: Oct. 11, 2018 · CIK: 0001175680 · Accession: 0000000000-18-031958

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-49908

Date

October 11, 2018

Author

Nader Z. Pourhassan, Ph.D.

Form

UPLOAD

Company

CytoDyn Inc. (CYDY) (CIK 0001175680)

Letter

October 11, 2018 Nader Z. Pourhassan, Ph.D. President and Chief Executive Officer CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, Washington 98660 Re:CytoDyn Inc. Preliminary Proxy Statement on Schedule 14A Filed September 7, 2018 File No. 000-49908 Dear Dr. Pourhassan: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Steven M. Skolnick - Lowenstein Sandler LLP

Show Raw Text

October 11, 2018
Nader Z. Pourhassan, Ph.D.
President and Chief Executive Officer
CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, Washington 98660
Re:CytoDyn Inc.
Preliminary Proxy Statement on Schedule 14A
Filed September 7, 2018
File No. 000-49908
Dear Dr. Pourhassan:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc:       Steven M. Skolnick - Lowenstein Sandler LLP

SecProbe.io